VA Connecticut Healthcare System, Newington, Connecticut, USA.
CNS Drugs. 2010 Dec;24(12):997-1007. doi: 10.2165/11539710-000000000-00000.
Post-traumatic stress disorder (PTSD) is a chronic and disabling psychiatric disorder with an estimated lifetime prevalence of 7.8%. Co-morbid alcohol dependence is a common clinical occurrence with important clinical considerations. For example, in individuals with both PTSD and alcohol dependence, the symptoms of PTSD tend to be more severe, and there is evidence that these individuals are more prone to alcohol use relapse than non-co-morbid individuals. Co-morbidity of PTSD and alcohol dependence is also associated with a higher rate of psychosocial and medical problems and higher utilization of inpatient hospitalization than either disorder alone. This article highlights the epidemiology of alcohol dependence in PTSD and reviews the evidence for effective treatments. Management of these individuals requires an understanding of the epidemiology and an awareness of treatment interventions, which include both psychosocial treatments (e.g. Seeking Safety, Concurrent Treatment of PTSD and Cocaine Dependence, Transcend, Trauma Recovery and Empowerment Model) and pharmacotherapy (e.g. selective serotonin reuptake inhibitors [SSRIs] and topiramate). Effective treatment of co-morbid PTSD and alcohol dependence may include a combination of these psychosocial and pharmacological interventions. The key element seems to be to ensure an adequate intervention for each disorder administered collaboratively.
创伤后应激障碍(PTSD)是一种慢性和致残性精神障碍,估计终身患病率为 7.8%。共病酒精依赖是一种常见的临床现象,具有重要的临床意义。例如,在同时患有 PTSD 和酒精依赖的个体中,PTSD 的症状往往更为严重,有证据表明,这些个体比非共病个体更容易发生酒精使用复发。PTSD 和酒精依赖的共病也与更高的心理社会和医疗问题发生率以及更高的住院治疗利用率有关,而不是单独的任何一种疾病。本文重点介绍 PTSD 中酒精依赖的流行病学,并回顾有效治疗的证据。这些个体的管理需要了解流行病学和治疗干预措施的意识,其中包括心理社会治疗(例如,寻求安全、同时治疗 PTSD 和可卡因依赖、超越、创伤恢复和赋权模式)和药物治疗(例如,选择性 5-羟色胺再摄取抑制剂[SSRIs]和托吡酯)。共病 PTSD 和酒精依赖的有效治疗可能包括这些心理社会和药物干预的组合。关键要素似乎是确保协同管理对每个疾病进行充分的干预。